Related Experiment Videos
Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease
1Department of Cardiac Surgery, Karl-Franzens University School of Medicine, Graz, Austria. olaf.stanger@kfunigraz.ac.at
Clinical Chemistry and Laboratory Medicine
|October 11, 2001
Summary
Elevated homocysteine levels are a significant risk factor for vascular disease. Lowering homocysteine through vitamin supplementation may protect blood vessels and improve endothelial function.
Area of Science:
- Vascular Biology
- Cardiovascular Disease
- Endothelial Function
Background:
- Elevated plasma homocysteine is a major risk factor for atherosclerosis and thrombosis.
- Moderate hyperhomocysteinemia increases mortality risk in cardiovascular disease patients.
- Mechanisms of homocysteine-induced vascular damage are not fully understood.
Purpose of the Study:
- To investigate the role of homocysteine in endothelium-dependent function.
- To understand the clinical implications for cardiovascular disease treatment.
- To explore the reversibility of homocysteine's damaging effects on endothelium.
Main Methods:
- Examining endothelium-dependent function in healthy and cardiovascular patients.
- Assessing the impact of acute and chronic homocysteine exposure on endothelial cells.
- Investigating the effects of homocysteine on vascular homeostasis and morphology.
Main Results:
- Homocysteine exposure impairs endothelial function, altering homeostasis and vessel wall morphology.
- Endothelial dysfunction is an early event in vascular pathology.
- Damaging effects of hyperhomocysteinemia on endothelium are partially reversible.
Conclusions:
- Homocysteine significantly impacts endothelial function, contributing to vascular damage.
- Vitamin supplementation may offer vasoprotective effects by lowering homocysteine.
- Further research into homocysteine-lowering therapies is warranted for cardiovascular disease prevention and treatment.